BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27838150)

  • 1. Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume.
    Chang JS; Byun HK; Kim JW; Kim KH; Lee J; Cho Y; Lee IJ; Keum KC; Suh CO; Kim YB
    Radiother Oncol; 2017 Jan; 122(1):24-29. PubMed ID: 27838150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume.
    Chang JS; Lee J; Chun M; Shin KH; Park W; Lee JH; Kim JH; Yoon WS; Lee IJ; Kim J; Park HL; Kim YB
    Radiother Oncol; 2018 Jan; 126(1):139-147. PubMed ID: 29050960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Locoregional control and patterns of locoregional failure in women with breast cancer treated by highly conformal electron beam irradiation].
    Loganadane G; Xi Z; Fournier-Bidoz N; Xu HP; Grellier Adedjouma N; Bazire L; Fourquet A; Kirova YM
    Cancer Radiother; 2019 Feb; 23(1):38-45. PubMed ID: 30595340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases.
    Beaton L; Nica L; Tyldesley S; Sek K; Ayre G; Aparicio M; Gondara L; Speers C; Nichol A
    Radiat Oncol; 2020 Jun; 15(1):136. PubMed ID: 32487183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The patterns and spatial locations of local recurrence in breast cancer with implant-based reconstruction after mastectomy.
    Joo JH; Yang JD; Park HY; Park J; Wu ZY; Ko B; Park J; Kim SS
    Radiother Oncol; 2022 May; 170():111-117. PubMed ID: 35245569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of PET/CT-based regional nodes distribution of recurrent/advanced breast cancer and comparison with current delineation atlas.
    Zhang M; Cao L; Chen J; Li B; Huang X; Cai G; Xu C
    Br J Radiol; 2022 Sep; 95(1137):20220382. PubMed ID: 35731844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
    Chen SA; Schuster DM; Mister D; Liu T; Godette K; Torres MA
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):309-14. PubMed ID: 23312271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer.
    Offersen BV; Boersma LJ; Kirkove C; Hol S; Aznar MC; Biete Sola A; Kirova YM; Pignol JP; Remouchamps V; Verhoeven K; Weltens C; Arenas M; Gabrys D; Kopek N; Krause M; Lundstedt D; Marinko T; Montero A; Yarnold J; Poortmans P
    Radiother Oncol; 2015 Jan; 114(1):3-10. PubMed ID: 25630428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer.
    DeSelm C; Yang TJ; Cahlon O; Tisnado J; Khan A; Gillespie E; Powell S; Ho A
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):583-591. PubMed ID: 30367906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy.
    Brown LC; Diehn FE; Boughey JC; Childs SK; Park SS; Yan ES; Petersen IA; Mutter RW
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):642-9. PubMed ID: 25936809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping Patterns of Ipsilateral Supraclavicular Nodal Metastases in Breast Cancer: Rethinking the Clinical Target Volume for High-risk Patients.
    Jing H; Wang SL; Li J; Xue M; Xiong ZK; Jin J; Wang WH; Song YW; Liu YP; Ren H; Fang H; Yu ZH; Liu XF; Li YX
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):268-76. PubMed ID: 26383676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
    Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location.
    Yu W; Hu W; Shui Y; Zhu X; Li C; Ren X; Bai X; Yu R; Shen L; Liang T; Zheng L; Wei Q
    Radiat Oncol; 2016 Oct; 11(1):138. PubMed ID: 27756417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
    Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
    BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atlas of sentinel lymph nodes in early breast cancer using single-photon emission computed tomography: implication for lymphatic contouring.
    Novikov SN; Krzhivitskii PI; Melnik YS; Valitova AA; Bryantseva ZV; Akulova IA; Kanaev SV
    Radiat Oncol J; 2021 Mar; 39(1):8-14. PubMed ID: 33794569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors influencing clinical target volume delineation of intact breast in intensity-modulated radiotherapy for breast cancer].
    Huang XB; Chen JY; Jiang GL
    Ai Zheng; 2006 Jan; 25(1):62-5. PubMed ID: 16405751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
    Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
    Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.